APO Research
Talk to an analyst

APO RESEARCH · REPORT

FAP Inhibitor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global FAP Inhibitor Industry Growth and Trends Forecast to 2032

28 December 202594 pages

Choose your research edition.

Industry ResearchFAP Inhibitor Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal FAP Inhibitor Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal FAP Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal FAP Inhibitor Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal FAP Inhibitor Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global FAP Inhibitor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for FAP Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for FAP Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for FAP Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of FAP Inhibitor include SOFIE, Ferronova, GE HealthCare, Isotopia, Lantheus, Bayer and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global FAP Inhibitor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The FAP Inhibitor market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global FAP Inhibitor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to FAP Inhibitor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global FAP Inhibitor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

FAP Inhibitor Market by Company

SOFIE

Ferronova

GE HealthCare

Isotopia

Lantheus

Bayer

Novartis AG

FAP Inhibitor Segment by Type

Ga-labeled

F-labeled

Other

FAP Inhibitor Segment by Application

Tumor Diagnosis

Tumor Treatment

Others

FAP Inhibitor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global FAP Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of FAP Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of FAP Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of FAP Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of FAP Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ga-labeled Table 2. Major Company of F-labeled Table 3. Major Company of Other Table 4. Global FAP Inhibitor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global FAP Inhibitor Sales by Type (2021-2026) & (K Units) Table 6. Global FAP Inhibitor Sales Market Share in Volume by Type (2021-2026) Table 7. Global FAP Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 8. Global FAP Inhibitor Sales Market Share in Value by Type (2021-2026) Table 9. Global FAP Inhibitor Price by Type (2021-2026) & (US$/Unit) Table 10. Global FAP Inhibitor Sales by Type (2027-2032) & (K Units) Table 11. Global FAP Inhibitor Sales Market Share in Volume by Type (2027-2032) Table 12. Global FAP Inhibitor Sales by Type (2027-2032) & (US$ Million) Table 13. Global FAP Inhibitor Sales Market Share in Value by Type (2027-2032) Table 14. Global FAP Inhibitor Price by Type (2027-2032) & (US$/Unit) Table 15. North America FAP Inhibitor Sales by Type (2021-2026) & (K Units) Table 16. North America FAP Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 17. Europe FAP Inhibitor Sales by Type (2021-2026) & (K Units) Table 18. Europe FAP Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific FAP Inhibitor Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific FAP Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America FAP Inhibitor Sales by Type (2021-2026) & (K Units) Table 22. Latin America FAP Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa FAP Inhibitor Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa FAP Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 25. FAP Inhibitor Industry Trends Table 26. FAP Inhibitor Industry Drivers Table 27. FAP Inhibitor Industry Opportunities and Challenges Table 28. FAP Inhibitor Industry Restraints Table 29. Global FAP Inhibitor Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global FAP Inhibitor Revenue Market Share by Company (2021-2026) Table 31. Global FAP Inhibitor Sales by Company (2021-2026) & (K Units) Table 32. Global FAP Inhibitor Sales Share by Company (2021-2026) Table 33. Global FAP Inhibitor Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global FAP Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global FAP Inhibitor Major Company Production Sites and Headquarters Table 36. Global FAP Inhibitor Company, Product Type & Application Table 37. Global FAP Inhibitor Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global FAP Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global FAP Inhibitor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global FAP Inhibitor Sales by Region (2021-2026) & (K Units) Table 42. Global FAP Inhibitor Sales Market Share in Volume by Region (2021-2026) Table 43. Global FAP Inhibitor Sales by Region (2021-2026) & (US$ Million) Table 44. Global FAP Inhibitor Sales Market Share in Value by Region (2021-2026) Table 45. Global FAP Inhibitor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global FAP Inhibitor Sales by Region (2027-2032) & (K Units) Table 47. Global FAP Inhibitor Sales Market Share in Volume by Region (2027-2032) Table 48. Global FAP Inhibitor Sales by Region (2027-2032) & (US$ Million) Table 49. Global FAP Inhibitor Sales Market Share in Value by Region (2027-2032) Table 50. Global FAP Inhibitor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global FAP Inhibitor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global FAP Inhibitor Sales by Application (2021-2026) & (K Units) Table 53. Global FAP Inhibitor Sales Market Share in Volume by Application (2021-2026) Table 54. Global FAP Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 55. Global FAP Inhibitor Sales Market Share in Value by Application (2021-2026) Table 56. Global FAP Inhibitor Price by Application (2021-2026) & (US$/Unit) Table 57. Global FAP Inhibitor Sales by Application (2027-2032) & (K Units) Table 58. Global FAP Inhibitor Sales Market Share in Volume by Application (2027-2032) Table 59. Global FAP Inhibitor Sales by Application (2027-2032) & (US$ Million) Table 60. Global FAP Inhibitor Sales Market Share in Value by Application (2027-2032) Table 61. Global FAP Inhibitor Price by Application (2027-2032) & (US$/Unit) Table 62. North America FAP Inhibitor Sales by Application (2021-2026) & (K Units) Table 63. North America FAP Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 64. Europe FAP Inhibitor Sales by Application (2021-2026) & (K Units) Table 65. Europe FAP Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific FAP Inhibitor Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific FAP Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America FAP Inhibitor Sales by Application (2021-2026) & (K Units) Table 69. Latin America FAP Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa FAP Inhibitor Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa FAP Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 72. SOFIE Company Information Table 73. SOFIE Business Overview Table 74. SOFIE FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. SOFIE FAP Inhibitor Product Portfolio Table 76. SOFIE Recent Development Table 77. Ferronova Company Information Table 78. Ferronova Business Overview Table 79. Ferronova FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Ferronova FAP Inhibitor Product Portfolio Table 81. Ferronova Recent Development Table 82. GE HealthCare Company Information Table 83. GE HealthCare Business Overview Table 84. GE HealthCare FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. GE HealthCare FAP Inhibitor Product Portfolio Table 86. GE HealthCare Recent Development Table 87. Isotopia Company Information Table 88. Isotopia Business Overview Table 89. Isotopia FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Isotopia FAP Inhibitor Product Portfolio Table 91. Isotopia Recent Development Table 92. Lantheus Company Information Table 93. Lantheus Business Overview Table 94. Lantheus FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Lantheus FAP Inhibitor Product Portfolio Table 96. Lantheus Recent Development Table 97. Bayer Company Information Table 98. Bayer Business Overview Table 99. Bayer FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bayer FAP Inhibitor Product Portfolio Table 101. Bayer Recent Development Table 102. Novartis AG Company Information Table 103. Novartis AG Business Overview Table 104. Novartis AG FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Novartis AG FAP Inhibitor Product Portfolio Table 106. Novartis AG Recent Development Table 107. North America FAP Inhibitor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. North America FAP Inhibitor Sales by Country (2021-2026) & (K Units) Table 109. North America FAP Inhibitor Sales Market Share by Country (2021-2026) Table 110. North America FAP Inhibitor Sales Forecast by Country (2027-2032) & (K Units) Table 111. North America FAP Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 112. North America FAP Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America FAP Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 114. North America FAP Inhibitor Market Share by Country (2021-2026) Table 115. North America FAP Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America FAP Inhibitor Market Share Forecast by Country (2027-2032) Table 117. Europe FAP Inhibitor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Europe FAP Inhibitor Sales by Country (2021-2026) & (K Units) Table 119. Europe FAP Inhibitor Sales Market Share by Country (2021-2026) Table 120. Europe FAP Inhibitor Sales Forecast by Country (2027-2032) & (K Units) Table 121. Europe FAP Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 122. Europe FAP Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe FAP Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe FAP Inhibitor Market Share by Country (2021-2026) Table 125. Europe FAP Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe FAP Inhibitor Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific FAP Inhibitor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific FAP Inhibitor Sales by Country (2021-2026) & (K Units) Table 129. Asia-Pacific FAP Inhibitor Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific FAP Inhibitor Sales Forecast by Country (2027-2032) & (K Units) Table 131. Asia-Pacific FAP Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific FAP Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific FAP Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific FAP Inhibitor Market Share by Country (2021-2026) Table 135. Asia-Pacific FAP Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific FAP Inhibitor Market Share Forecast by Country (2027-2032) Table 137. Latin America FAP Inhibitor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Latin America FAP Inhibitor Sales by Country (2021-2026) & (K Units) Table 139. Latin America FAP Inhibitor Sales Market Share by Country (2021-2026) Table 140. Latin America FAP Inhibitor Sales Forecast by Country (2027-2032) & (K Units) Table 141. Latin America FAP Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America FAP Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America FAP Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America FAP Inhibitor Market Share by Country (2021-2026) Table 145. Latin America FAP Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America FAP Inhibitor Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa FAP Inhibitor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa FAP Inhibitor Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa FAP Inhibitor Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa FAP Inhibitor Sales Forecast by Country (2027-2032) & (K Units) Table 151. Middle East and Africa FAP Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa FAP Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa FAP Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa FAP Inhibitor Market Share by Country (2021-2026) Table 155. Middle East and Africa FAP Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa FAP Inhibitor Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. FAP Inhibitor Distributors List Table 160. FAP Inhibitor Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. FAP Inhibitor Image Figure 2. Global FAP Inhibitor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global FAP Inhibitor Market Size (2021-2032) & (US$ Million) Figure 4. Global FAP Inhibitor Sales (2021-2032) & (K Units) Figure 5. Ga-labeled Image Figure 6. Global Ga-labeled Sales YoY Growth (2021-2032) & (K Units) Figure 7. F-labeled Image Figure 8. Global F-labeled Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global FAP Inhibitor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global FAP Inhibitor Market Share by Type 2025 VS 2032 Figure 13. North America FAP Inhibitor Sales Market Share in Volume by Type in 2025 Figure 14. North America FAP Inhibitor Sales Market Share in Value by Type in 2025 Figure 15. Europe FAP Inhibitor Sales Market Share in Volume by Type in 2025 Figure 16. Europe FAP Inhibitor Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific FAP Inhibitor Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific FAP Inhibitor Sales Market Share in Value by Type in 2025 Figure 19. Latin America FAP Inhibitor Sales Market Share in Volume by Type in 2025 Figure 20. Latin America FAP Inhibitor Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa FAP Inhibitor Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa FAP Inhibitor Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 FAP Inhibitor Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Tumor Diagnosis Image Figure 26. Global Tumor Diagnosis Sales YoY Growth (2021-2032) & (K Units) Figure 27. Tumor Treatment Image Figure 28. Global Tumor Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global FAP Inhibitor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global FAP Inhibitor Market Share by Application 2025 VS 2032 Figure 33. North America FAP Inhibitor Sales Market Share in Volume by Application in 2025 Figure 34. North America FAP Inhibitor Sales Market Share in Value by Application in 2025 Figure 35. Europe FAP Inhibitor Sales Market Share in Volume by Application in 2025 Figure 36. Europe FAP Inhibitor Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific FAP Inhibitor Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific FAP Inhibitor Sales Market Share in Value by Application in 2025 Figure 39. Latin America FAP Inhibitor Sales Market Share in Volume by Application in 2025 Figure 40. Latin America FAP Inhibitor Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa FAP Inhibitor Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa FAP Inhibitor Sales Market Share in Value by Application in 2025 Figure 43. North America FAP Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America FAP Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America FAP Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America FAP Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe FAP Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe FAP Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe FAP Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe FAP Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific FAP Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific FAP Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific FAP Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific FAP Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America FAP Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America FAP Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America FAP Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America FAP Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa FAP Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa FAP Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa FAP Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa FAP Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. FAP Inhibitor Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. FAP Inhibitor Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Ga-labeled
  • F-labeled
  • Other
Applications
  • Tumor Diagnosis
  • Tumor Treatment
  • Others
Companies covered
  • SOFIE
  • Ferronova
  • GE HealthCare
  • Isotopia
  • Lantheus
  • Bayer
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global FAP Inhibitor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global FAP Inhibitor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 FAP Inhibitor Market by Type
  6. 1.3.1 Ga-labeled
  7. 1.3.2 F-labeled
  8. 1.3.3 Other
  9. 1.4 Global FAP Inhibitor Market Size by Type
  10. 1.4.1 Global FAP Inhibitor Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global FAP Inhibitor Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global FAP Inhibitor Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America FAP Inhibitor Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe FAP Inhibitor Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific FAP Inhibitor Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America FAP Inhibitor Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa FAP Inhibitor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 FAP Inhibitor Industry Trends
  2. 2.2 FAP Inhibitor Industry Drivers
  3. 2.3 FAP Inhibitor Industry Opportunities and Challenges
  4. 2.4 FAP Inhibitor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by FAP Inhibitor Revenue (2021-2026)
  2. 3.2 Global Top Players by FAP Inhibitor Sales (2021-2026)
  3. 3.3 Global Top Players by FAP Inhibitor Price (2021-2026)
  4. 3.4 Global FAP Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global FAP Inhibitor Major Company Production Sites & Headquarters
  6. 3.6 Global FAP Inhibitor Company, Product Type & Application
  7. 3.7 Global FAP Inhibitor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global FAP Inhibitor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 FAP Inhibitor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 FAP Inhibitor Tier 1, Tier 2, and Tier 3
4 FAP Inhibitor Regional Status and Outlook
  1. 4.1 Global FAP Inhibitor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global FAP Inhibitor Historic Market Size by Region
  3. 4.2.1 Global FAP Inhibitor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global FAP Inhibitor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global FAP Inhibitor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global FAP Inhibitor Forecasted Market Size by Region
  7. 4.3.1 Global FAP Inhibitor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global FAP Inhibitor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global FAP Inhibitor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 FAP Inhibitor by Application
  1. 5.1 FAP Inhibitor Market by Application
  2. 5.1.1 Tumor Diagnosis
  3. 5.1.2 Tumor Treatment
  4. 5.1.3 Others
  5. 5.2 Global FAP Inhibitor Market Size by Application
  6. 5.2.1 Global FAP Inhibitor Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global FAP Inhibitor Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global FAP Inhibitor Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America FAP Inhibitor Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe FAP Inhibitor Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific FAP Inhibitor Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America FAP Inhibitor Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa FAP Inhibitor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 SOFIE
  2. 6.1.1 SOFIE Company Information
  3. 6.1.2 SOFIE Business Overview
  4. 6.1.3 SOFIE FAP Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 SOFIE FAP Inhibitor Product Portfolio
  6. 6.1.5 SOFIE Recent Developments
  7. 6.2 Ferronova
  8. 6.2.1 Ferronova Company Information
  9. 6.2.2 Ferronova Business Overview
  10. 6.2.3 Ferronova FAP Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ferronova FAP Inhibitor Product Portfolio
  12. 6.2.5 Ferronova Recent Developments
  13. 6.3 GE HealthCare
  14. 6.3.1 GE HealthCare Company Information
  15. 6.3.2 GE HealthCare Business Overview
  16. 6.3.3 GE HealthCare FAP Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GE HealthCare FAP Inhibitor Product Portfolio
  18. 6.3.5 GE HealthCare Recent Developments
  19. 6.4 Isotopia
  20. 6.4.1 Isotopia Company Information
  21. 6.4.2 Isotopia Business Overview
  22. 6.4.3 Isotopia FAP Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Isotopia FAP Inhibitor Product Portfolio
  24. 6.4.5 Isotopia Recent Developments
  25. 6.5 Lantheus
  26. 6.5.1 Lantheus Company Information
  27. 6.5.2 Lantheus Business Overview
  28. 6.5.3 Lantheus FAP Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lantheus FAP Inhibitor Product Portfolio
  30. 6.5.5 Lantheus Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer FAP Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer FAP Inhibitor Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 Novartis AG
  38. 6.7.1 Novartis AG Company Information
  39. 6.7.2 Novartis AG Business Overview
  40. 6.7.3 Novartis AG FAP Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Novartis AG FAP Inhibitor Product Portfolio
  42. 6.7.5 Novartis AG Recent Developments
7 North America by Country
  1. 7.1 North America FAP Inhibitor Sales by Country
  2. 7.1.1 North America FAP Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America FAP Inhibitor Sales by Country (2021-2026)
  4. 7.1.3 North America FAP Inhibitor Sales Forecast by Country (2027-2032)
  5. 7.2 North America FAP Inhibitor Market Size by Country
  6. 7.2.1 North America FAP Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America FAP Inhibitor Market Size by Country (2021-2026)
  8. 7.2.3 North America FAP Inhibitor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe FAP Inhibitor Sales by Country
  2. 8.1.1 Europe FAP Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe FAP Inhibitor Sales by Country (2021-2026)
  4. 8.1.3 Europe FAP Inhibitor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe FAP Inhibitor Market Size by Country
  6. 8.2.1 Europe FAP Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe FAP Inhibitor Market Size by Country (2021-2026)
  8. 8.2.3 Europe FAP Inhibitor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific FAP Inhibitor Sales by Country
  2. 9.1.1 Asia-Pacific FAP Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific FAP Inhibitor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific FAP Inhibitor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific FAP Inhibitor Market Size by Country
  6. 9.2.1 Asia-Pacific FAP Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific FAP Inhibitor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific FAP Inhibitor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America FAP Inhibitor Sales by Country
  2. 10.1.1 South America FAP Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America FAP Inhibitor Sales by Country (2021-2026)
  4. 10.1.3 South America FAP Inhibitor Sales Forecast by Country (2027-2032)
  5. 10.2 South America FAP Inhibitor Market Size by Country
  6. 10.2.1 South America FAP Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America FAP Inhibitor Market Size by Country (2021-2026)
  8. 10.2.3 South America FAP Inhibitor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa FAP Inhibitor Sales by Country
  2. 11.1.1 Middle East and Africa FAP Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa FAP Inhibitor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa FAP Inhibitor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa FAP Inhibitor Market Size by Country
  6. 11.2.1 Middle East and Africa FAP Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa FAP Inhibitor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa FAP Inhibitor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 FAP Inhibitor Value Chain Analysis
  2. 12.1.1 FAP Inhibitor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 FAP Inhibitor Production Mode & Process
  7. 12.2 FAP Inhibitor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 FAP Inhibitor Distributors
  10. 12.2.3 FAP Inhibitor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst